1,3,4-thiadiazole derivatives.: Synthesis, structure elucidation, and structure-antituberculosis activity relationship investigation

被引:218
作者
Oruç, EE
Rollas, S [1 ]
Kandemirli, F
Shvets, N
Dimoglo, AS
机构
[1] Marmara Univ, Fac Pharm, Dept Pharmaceut Chem, TR-81010 Istanbul, Turkey
[2] Kocaeli Univ, Dept Chem, TR-41400 Izmit, Turkey
[3] Inst Technol, TR-41400 Kocaeli, Turkey
[4] Moldavian Acad Sci, Math Inst, Kishinev 2028, Moldova
[5] Inst Chem, Dept Quantum Chem, Kishinev 2028, Moldova
关键词
D O I
10.1021/jm0495632
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A series of 2,5-disubstituted-1,3,4-thiadiazoles were synthesized, the compounds structures were elucidated and screened for the antituberculosis activity against Mycobacterium tuberculosis H37Rv using the BACTEC 460 radiometric system. Among the tested compounds, 2-phenylamino-5-(4-fluorophenyl)-1,3,4-thiadiazole 22 showed the highest inhibitory activity. The relationships between the structures of compounds and their antituberculosis activity were investigated by the Electronic-Topological Method (ETM) and feed forward neural networks (FFNNs) trained with the back-propagation algorithm. As a result of the approach, a system of pharmacophores and anti-pharmacophores has been found that effectively separates compounds of the examination set into groups of active and inactive compounds. The system can be applied to the screening and design of new active compounds possessing skeletons similar to those used in the present study.
引用
收藏
页码:6760 / 6767
页数:8
相关论文
共 55 条
[21]  
KANDEMIRLI F, 2003, ARZNEIM FORSCH DRUG, V2, P133
[22]   Synthesis and antituberculosis activity of new N-phenyl-N′-[4-(5-alkyl/arylamino-1,3,4-thiadiazole-2-yl)phenyl]thioureas [J].
Karakus, S ;
Rollas, S .
FARMACO, 2002, 57 (07) :577-581
[23]  
KARAKUS S, 2003, 4 INT S PHARM CHEM S
[24]   Neural network studies. 3. Variable selection in the cascade-correlation learning architecture [J].
Kovalishyn, VV ;
Tetko, IV ;
Luik, AI ;
Kholodovych, VV ;
Villa, AEP ;
Livingstone, DJ .
JOURNAL OF CHEMICAL INFORMATION AND COMPUTER SCIENCES, 1998, 38 (04) :651-659
[25]  
Labanauskas L, 2001, PHARMAZIE, V56, P617
[26]  
Mamolo MG, 1996, FARMACO, V51, P71
[27]  
MARTVON A, 1980, CHEM ZVESTI, V34, P118
[28]  
MAZZONE G, 1993, FARMACO, V48, P1207
[29]  
MIYAMOTO K, 1985, CHEM PHARM BULL, V33, P5126
[30]   DESIGN OF 5-(3,5-DI-TERT-BUTYL-4-HYDROXYPHENYL)-1,3,4-THIADIAZOLES, 5-(3,5-DI-TERT-BUTYL-4-HYDROXYPHENYL)-1,3,4-OXADIAZOLES, AND 5-(3,5-DI-TERT-BUTYL-4-HYDROXYPHENYL)-1,2,4-TRIAZOLES AS ORALLY-ACTIVE, NONULCEROGENIC ANTIINFLAMMATORY AGENTS [J].
MULLICAN, MD ;
WILSON, MW ;
CONNOR, DT ;
KOSTLAN, CR ;
SCHRIER, DJ ;
DYER, RD .
JOURNAL OF MEDICINAL CHEMISTRY, 1993, 36 (08) :1090-1099